TrialOncology research and treatment2025

Palbociclib in Combination with either Aromatase Inhibitors or Fulvestrant for Patients with Advanced HR+/HER2- Breast Cancer in Germany: Final Results of the Phase 2 Multicohort INGE-B Trial.

Manfred Welslau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.